Published in Br J Cancer on February 05, 2008
Guidelines for the welfare and use of animals in cancer research. Br J Cancer (2010) 6.97
Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer (2010) 2.04
Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. BMC Cancer (2013) 1.40
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res (2011) 1.23
Platelets govern pre-metastatic tumor communication to bone. Oncogene (2013) 0.85
Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model. Neoplasia (2010) 0.84
STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody. Nat Commun (2015) 0.81
Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength. Osteoporos Int (2014) 0.79
Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases. Int J Cell Biol (2014) 0.78
The role of macrophages in bone metastasis. J Bone Oncol (2013) 0.75
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95
Osteoclast differentiation and activation. Nature (2003) 18.59
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer (2002) 12.45
Mechanisms of bone metastasis. N Engl J Med (2004) 10.40
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer (2006) 8.59
Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev (2001) 6.57
General mechanisms of metastasis. Cancer (1997) 3.71
Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer (2005) 2.86
Mechanisms of bone metastasis. Cancer (1997) 2.29
Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology (1999) 2.11
Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology (2005) 1.85
Cancer and bone. Endocr Rev (1998) 1.77
Stromal factors involved in prostate carcinoma metastasis to bone. Cancer (2003) 1.63
Role of endothelin-1 in osteoblastic bone metastases. Cancer (2003) 1.54
Molecular mechanisms of osteolytic bone metastases. Cancer (2000) 1.47
The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev (2005) 1.47
LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res (2004) 1.45
Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev (2001) 1.41
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol (2002) 1.35
Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie (2005) 1.33
Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res (1994) 1.33
Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo. Int J Cancer (1999) 1.16
Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res (2004) 1.15
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. J Orthop Res (2003) 1.14
Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem (2000) 1.12
Activin, inhibin and the human breast. Mol Cell Endocrinol (2004) 1.10
Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases. J Bone Miner Res (2001) 1.08
Role of stromal-derived cytokines and growth factors in bone metastasis. Cancer (2003) 1.06
Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol (1986) 1.05
Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. Basic Appl Histochem (1983) 0.98
Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica (2000) 0.95
Osteoblast lineage properties in giant cell tumors of bone. J Orthop Sci (2005) 0.93
Rat models of bone metastases. Clin Exp Metastasis (2006) 0.90
Growth regulatory factors and bone. Rev Endocr Metab Disord (2001) 0.89
Iron in neoplastic disease. Nutr Cancer (1983) 0.88
Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation. Hum Pathol (1996) 0.88
Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat. J Cancer Res Clin Oncol (1986) 0.86
Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience. Leukemia (1987) 0.84
Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone (2003) 0.81
Histological observations on the microenvironment of osteolytic bone metastasis by breast carcinoma cell line. Biomed Res (2005) 0.80
The contribution of inhibins and activins to malignant prostate disease. Mol Cell Endocrinol (2001) 0.80
Selection of a highly aggressive myeloma cell line by an altered bone microenvironment in the C57BL/KaLwRij mouse. Biochem Biophys Res Commun (2004) 0.78
The Walker 256/B carcinosarcoma in thyroparathyroidectomized rats: a model to evaluate inhibitors of bone resorption. Calcif Tissue Int (1987) 0.76
Fracture incidence after 3 years of aromatase inhibitor therapy. Ann Oncol (2014) 3.18
Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab (1997) 2.43
Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res (2000) 1.91
Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase. Clin Exp Allergy (2009) 1.51
Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma. J Clin Invest (1991) 1.38
Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol (1989) 1.33
B cell malignancies presenting with unusual bone involvement and mimicking multiple myeloma. Study of nine cases. Am J Med (1987) 1.23
Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol (1998) 1.23
Effects of roughness, fibronectin and vitronectin on attachment, spreading, and proliferation of human osteoblast-like cells (Saos-2) on titanium surfaces. Calcif Tissue Int (1999) 1.20
Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol (1986) 1.18
Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities. Acta Histochem (1987) 1.16
Influence of fluoride, hydrogen peroxide and lactic acid on the corrosion resistance of commercially pure titanium. Acta Biomater (2005) 1.10
Abnormal serum bone Gla protein levels in multiple myeloma. Crucial role of bone formation and prognostic implications. Cancer (1990) 1.07
Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells. Biomaterials (2000) 1.05
Synchrotron X-ray microtomography (on a micron scale) provides three-dimensional imaging representation of bone ingrowth in calcium phosphate biomaterials. Biomaterials (2003) 1.02
Osteoporosis in men: a potential role for the sex hormone binding globulin. Bone (2001) 1.01
Image analysis measurements of roughness by texture and fractal analysis correlate with contact profilometry. Biomaterials (2003) 0.99
Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. Blood (1996) 0.99
Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. Basic Appl Histochem (1983) 0.98
New laboratory tools in the assessment of bone quality. Osteoporos Int (2011) 0.98
Uncalcified cartilage resorption in human fetal cartilage canals. Tissue Cell (1986) 0.97
Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol (2006) 0.95
Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int (2010) 0.95
Cancer-associated bone disease. Osteoporos Int (2013) 0.94
Effect of a five-week swimming program on rat bone: a histomorphometric study. Calcif Tissue Int (1992) 0.94
Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myeloma. Br J Haematol (1990) 0.93
Mechanisms of bone lesions in multiple myeloma. Hematol Oncol Clin North Am (1992) 0.91
Importance of quantitative histology of bone changes in monoclonal gammopathy. Br J Cancer (1986) 0.90
Contributions of chronological age, age at menarche and menopause and of anthropometric parameters to axial and peripheral bone densities. Osteoporos Int (1992) 0.90
Bone mineral density and vertebral fractures in men. Osteoporos Int (1999) 0.89
Effects of a 120 day period of bed-rest on bone mass and bone cell activities in man: attempts at countermeasure. Bone Miner (1987) 0.89
Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: comparison with normal postmenopausal women. Osteoporos Int (1990) 0.89
Fractal dimension of trabecular bone: comparison of three histomorphometric computed techniques for measuring the architectural two-dimensional complexity. J Pathol (2001) 0.88
Effects of negatively charged groups (carboxymethyl) on the calcification of poly(2-hydroxyethyl methacrylate). Biomaterials (2002) 0.88
Effects of the length of crosslink chain on poly(2-hydroxyethyl methacrylate) (pHEMA) swelling and biomechanical properties. J Biomed Mater Res A (2006) 0.88
On the trail of paramyxoviruses in Paget's disease of bone. Clin Orthop Relat Res (1987) 0.87
Disuse and orchidectomy have additional effects on bone loss in the aged male rat. Osteoporos Int (2006) 0.87
Fat in bone xenografts: importance of the purification procedures on cleanliness, wettability and biocompatibility. Biomaterials (1993) 0.86
Ex vivo bone mineral density of the wrist: influence of medullar fat. Bone (2004) 0.86
Osteoclastic resorption of Ca-P biomaterials implanted in rabbit bone. Calcif Tissue Int (1993) 0.86
Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma. Cancer (1988) 0.85
Osteoblast stimulation in multiple myeloma lacking lytic bone lesions. Br J Haematol (1990) 0.85
Migration of metal and polyethylene particles from articular prostheses may generate lymphadenopathy with histiocytosis. J Biomed Mater Res (1996) 0.85
Bone microarchitecture in males with corticosteroid-induced osteoporosis. Osteoporos Int (2006) 0.85
The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Int J Clin Lab Res (1992) 0.84
Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss. J Musculoskelet Neuronal Interact (2015) 0.83
Improved algorithms for automatic bone histomorphometry on a numerized image analysis system. J Microsc (1988) 0.83
[Necrotic livedo after injection of buprenorphine (Subutex)]. Ann Dermatol Venereol (2007) 0.83
Trabecular bone remodeling after seven days of weightlessness exposure (BIOCOSMOS 1667). Am J Physiol (1988) 0.83
Comparison of eight histomorphometric methods for measuring trabecular bone architecture by image analysis on histological sections. Microsc Res Tech (1999) 0.83
Evaluation of the osteoclastic population in iliac crest biopsies from 36 normal subjects: a histoenzymologic and histomorphometric study. J Bone Miner Res (1989) 0.83
Relations between radiograph texture analysis and microcomputed tomography in two rat models of bone metastases. Cells Tissues Organs (2006) 0.83
Lean, fat and bone masses are influenced by orchidectomy in the rat. A densitometric X-ray absorptiometric study. J Musculoskelet Neuronal Interact (2001) 0.82
Ultrastructural characteristics of glucocorticoid-induced osteoporosis. Osteoporos Int (2009) 0.82
Biodegradability of poly (2-hydroxyethyl methacrylate) in the presence of the J774.2 macrophage cell line. Biomaterials (2004) 0.82
Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices. J Microsc (2011) 0.82
[Giant cell tumors developing in Paget's disease. Presentation of 2 cases with an ultrastructural study]. Ann Pathol (1989) 0.82
Bone mass and microarchitecture of irradiated and bone marrow-transplanted mice: influences of the donor strain. Osteoporos Int (2008) 0.82
[Type I collagen in xenogenic bone material regulates attachment and spreading of osteoblasts over the beta1 integrin subunit]. Orthopade (1998) 0.82
Adherence of osteoblast-like cells on calcospherites developed on a biomaterial combining poly(2-hydroxyethyl) methacrylate and alkaline phosphatase. Bone (2002) 0.82
Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo. Br J Haematol (1995) 0.82
Shape and orientation of osteoblast-like cells (Saos-2) are influenced by collagen fibers in xenogenic bone biomaterial. J Biomed Mater Res (1998) 0.82
Disuse induced by botulinum toxin affects the bone marrow expression profile of bone genes leading to a rapid bone loss. J Musculoskelet Neuronal Interact (2013) 0.82
Influence of metal ion solutions on rabbit osteoclast activities in vitro. Histol Histopathol (2002) 0.82
Free radicals and side products released during methylmethacrylate polymerization are cytotoxic for osteoblastic cells. J Biomed Mater Res (1998) 0.82
Enhanced bone integration of implants with increased surface roughness: a long term study in the sheep. J Dent (2002) 0.81
Relationship between computed tomographic image analysis and histomorphometry for microarchitectural characterization of human calcaneus. Calcif Tissue Int (2004) 0.81
Poly(2-hydroxy ethyl methacrylate)-alkaline phosphatase: a composite biomaterial allowing in vitro studies of bisphosphonates on the mineralization process. J Biomater Sci Polym Ed (2000) 0.81
Embedding iliac bone biopsies at low temperature using glycol and methyl methacrylates. Stain Technol (1983) 0.80
High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy. Ann Oncol (2011) 0.80
Evaluation of an injectable bone substitute (betaTCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats. J Biomed Mater Res A (2006) 0.80
Synthesis of methacryloyloxyethyl phosphate copolymers and in vitro calcification capacity. Biomaterials (2004) 0.80
Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength. Osteoporos Int (2014) 0.79
Micro and macroarchitectural changes at the tibia after botulinum toxin injection in the growing rat. Bone (2012) 0.79
Hyperparathyroidism in proximal femur fractures biological and histomorphometric study in 21 patients over 75 years old. Clin Rheumatol (1991) 0.78
Texture analysis of X-ray radiographs of iliac bone is correlated with bone micro-CT. Osteoporos Int (2006) 0.78
Does titanium surface treatment influence the bone-implant interface? SEM and histomorphometry in a 6-month sheep study. Int J Oral Maxillofac Implants (1996) 0.78
Microcomputed tomography used in the analysis of the morphology of root canals in extracted wisdom teeth. Br J Oral Maxillofac Surg (2005) 0.78
Expression of prolactin receptors in human osteosarcoma cells. Biochem Biophys Res Commun (1996) 0.78
Comparison of histomorphometric descriptors of bone architecture with dual-energy X-ray absorptiometry for assessing bone loss in the orchidectomized rat. Osteoporos Int (2002) 0.78